Functionality clinical trials

Explore recruiting functionality clinical trials.

Recruiting functionality studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Functionality trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Microdosing with a serotonergic agent for ADHD and emotion regulation: biological factors explaining and predicting treatment response

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomized blinded placebo-controlled trial, the RASSc study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

An Exploratory, First-in-Human, study to investigate the safety and preliminary efficacy of InvivoLPrint-U-Therapy, a combination of an advanced therapy medicinal product (ATMP) of expanded autologous urothelial cells with an in vivo bioprinter for administration during orthotopic neobladder surgery

Greece

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

“Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM). Phase 3 pragmatic multicenter open labelled randomized trial.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicentre, intra-patient randomised controlled Phase III study to confirm the efficacy and safety of denovoSkin™, a bilayer engineered collagen-based skin graft composed of autologous fibroblasts and keratinocytes, for the treatment of patients with deep partial and full-thickness burns

Netherlands, Italy, Belgium, France, Portugal, Poland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Functionality trials by city

Functionality in Toronto Functionality in Vancouver Functionality in Montreal Functionality in Calgary Functionality in Edmonton Functionality in Ottawa Functionality in Winnipeg Functionality in Quebec City Functionality in Hamilton Functionality in Kitchener Functionality in London Functionality in Halifax Functionality in New York Functionality in Los Angeles Functionality in Chicago Functionality in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease